Cogstate Limited (ASX:CGS)

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Healthcare (Incl. Sport)	2.50M	2.51M	3.99M	4.40M	4.46M
Clinical Trials (incl. Precision Recruitment Tool & Research)	58.37M	50.58M	39.44M	36.05M	-
Unallocated Administration	-	-	-	-	53.09K
Clinical Trials (Incl. Precision Recruitment Tool)	-	-	-	-	40.33M
Research Solutions	-	-	-	-	195.51K
Total	60.86M	53.09M	43.43M	40.45M	45.03M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 30, 2026

Data Sources Report a data error